NWAM LLC’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$759K Buy
20,662
+15,872
+331% +$752K 0.04% 329
2025
Q4
$306K Buy
+4,790
New +$245K 0.02% 496
2025
Q1
Sell
-2,693
Closed -$232K 572
2024
Q4
$232K Sell
2,693
-80
-3% -$8.65K 0.01% 541
2024
Q3
$330K Buy
+2,773
New +$370K 0.02% 472
2024
Q2
Sell
-3,831
Closed -$488K 406
2024
Q1
$488K Buy
3,831
+1,299
+51% +$155K 0.04% 342
2023
Q4
$262K Sell
2,532
-15
-0.6% -$1.48K 0.02% 469
2023
Q3
$232K Buy
+2,547
New +$224K 0.02% 441
2023
Q2
Sell
-2,778
Closed -$221K 564
2023
Q1
$221K Buy
+2,778
New +$197K 0.02% 435

Other funds holding NVO

NWAM LLC's NVO Position: Q1 2026 in Review

NWAM LLC increased its Novo Nordisk (NVO) stake by 331% in Q1 2026, buying an estimated $752K and bringing the position to 20,662 shares worth $759K. The position accounts for 0.04% of the portfolio, ranked #329.

NWAM LLC first reported a position in NVO in Q1 2023 and has held it in 8 quarters since. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • NWAM LLC held 20,662 shares of Novo Nordisk worth $759K as of Q1 2026.
  • NWAM LLC bought 15,872 Novo Nordisk shares in Q1 2026, an estimated $752K.
  • Novo Nordisk made up 0.04% of NWAM LLC's portfolio in Q1 2026, its #329 holding.
  • NWAM LLC first reported a position in Novo Nordisk in Q1 2023 and has held it in 8 quarters since.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.